Morgan Stanley downgraded Clarivate (CLVT) to Underweight from Equal Weight with a price target of $3, down from $5. The firm sees continued share underperformance for Clarivate as its turnaround “continues to struggle.” The company faces tight budgets and competition, and its strategic review will not yield much value, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLVT:
- Clarivate launches Cortellis Regulatory Intelligence AI Assistant
- Clarivate’s Mixed Financial Signals Lead to Hold Rating Despite Revenue Beat
- Clarivate files automatic mixed securities shelf
- Clarivate files to sell 245.08M ordinary shares for holders
- Clarivate price target lowered to $4.20 from $4.80 at Goldman Sachs